Document is current
Any future updates will be listed below
-
Authors
Liu, Chang
Khairullina, Liliia
Qin, Youyou
Zhang, Yingbo
Xiao, Zhibo
-
Funding
Funding for this research was provided by:
Reform and Development of Local Col-leges (2021-理工类-高水平人才13)
National Natural Science Foundation of China (No. 81471796)
Excellent Youth Foundation of Heilongjiang Province of China (JC2017019)
Scientific Research Innovation Project of Harbin Medical University (YJSCX2020-39HYD)
- License Information
-
More Information
Article History
Received: 6 August 2024
Accepted: 5 September 2024
First Online: 15 September 2024
Declarations
:
: This study was approved by the Institutional Review Board of the Second Hospital of Harbin Medical University (Approval number: YJSKY2022-346, Date of approval: August 23, 2022) and adhered to the tenants of the Declaration of Helsinki. The patients provided written informed consent for the use of the samples. The animal experiment was approved by the Animal Ethical Committee of the Second Hospital of Harbin Medical University (Approval number: SYDW2022-188, Date of approval: August 23, 2022). Title of the approved project for both animal and human studies: Adipose stem cell exosomes inhibit keloids through PI3K/AKT pathway. All operations involving animal experiments in this experiment strictly follow the guidelines outlined in the revised Animals (Scientific Procedures) Act 1986 in the UK and Directive 2010/63/EU in Europe.
: All authors consent for publication.
: The author(s) declare no competing interests.
